ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,081Medicare Part D Prescriptions Filled, Including Refills

Rank: 160 out of 1171

$530K Total Retail Price of All Prescriptions

Rank: 193 out of 1171

521 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 521 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 521 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 7,461 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 503 432 1 2
LISINOPRIL 391 289 2 3
SIMVASTATIN 377 343 3 1
HYDROCHLOROTHIAZIDE 304 234 4 9
OMEPRAZOLE 287 186 5 5
METFORMIN HCL 280 203 6 7
LEVOTHYROXINE SODIUM 242 202 7 4
FUROSEMIDE 217 139 8 6
TRAMADOL HCL 199 140 9 18
METOPROLOL TARTRATE 194 166 10 11
ATORVASTATIN CALCIUM 190 151 11 10
POTASSIUM CHLORIDE 173 120 12 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 161 140 13 26
ZOLPIDEM TARTRATE 158 81 14 21
PRAVASTATIN SODIUM 155 113 15 13
ALLOPURINOL 153 113 16 31
ATENOLOL 153 147 16 15
LOSARTAN-HYDROCHLOROTHIAZIDE 142 110 18 40
CITALOPRAM HBR 131 112 19 22
GABAPENTIN 114 69 20 16
AMITRIPTYLINE HCL 106 49 R 21 74
DIOVAN 105 92 22 32
FLUTICASONE PROPIONATE 104 43 23 30
FENOFIBRATE 102 73 24 81
LOSARTAN POTASSIUM 98 66 25 14
NAPROXEN 97 61 26 95
NAMENDA 96 91 27 42
METOPROLOL SUCCINATE 87 75 28 17
CRESTOR 86 70 29 27
GLIMEPIRIDE 82 49 30 34
WARFARIN SODIUM 79 59 31 12
DIOVAN HCT 79 71 31 65
KLOR-CON 10 73 62 33 126
CLOPIDOGREL 70 59 34 35
HYDROCODONE-ACETAMINOPHEN 69 33 S3 35 8
SERTRALINE HCL 66 64 36 23
ALENDRONATE SODIUM 64 62 37 33
PROAIR HFA 63 27 38 49
TAMSULOSIN HCL 61 29 39 28
ADVAIR DISKUS 60 43 40 51
CARVEDILOL 59 44 41 20
AGGRENOX 57 43 42 148
OXYCODONE-ACETAMINOPHEN 55 28 S2 43 59
NEXIUM 55 28 43 25
DONEPEZIL HCL 55 55 43 24
CLONIDINE HCL 52 36 46 45
INSULIN SYRINGE 51 38 47 71
ZETIA 50 30 48 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.